NVON.MX
Novo Nordisk A/S News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 3,
"returned": 3,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "d68f527d-7689-4cbc-a1ad-b70730584b61",
"title": "Absci: 'AI' Tag Keeping Company Afloat While Searching For Right Formula (NASDAQ:ABSI)",
"description": "AI-driven drug discovery company, Absci Corporation, struggles with share price performance after IPO. Click for my ABSI stock update and look ahead.",
"keywords": "",
"snippet": "Three Images\n\nInvestment Overview - Absci - Another AI-Driven Drug Developer With a Compromised Share Price\n\nAbsci Corporation (NASDAQ:ABSI) is a Vancouver-base...",
"url": "https://seekingalpha.com/article/4693987-absci-ai-tag-keeping-company-afloat-while-searching-for-right-formula",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/83803495/image_83803495.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2024-05-16T22:36:07.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "NVON.MX",
"name": "Novo Nordisk A/S",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 14.197201,
"sentiment_score": 0.0772,
"highlights": [
{
"highlight": "The likes of >$25bn per annum cancer drug Keytruda, >$20bn selling (until 2023) autoimmune drug Humira, and even the GLP-1 agonist drugs developed by Eli Lilly and Company (LLY) and <em>Novo</em> <em>Nordisk</em> <em>A</em>/<em>S</em> (NVO), better known as Zepbound and Wegovy, and tipped to earn hundreds of billions of dollars of revenues over the next decade, were not discovered using",
"sentiment": 0.0772,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "b7bd08d1-de19-439d-9ed8-276f3b872a10",
"title": "Denmark stocks higher at close of trade; OMX Copenhagen 20 up 0.01% By Investing.com",
"description": "Denmark stocks higher at close of trade; OMX Copenhagen 20 up 0.01%",
"keywords": "",
"snippet": "Investing.com – Denmark stocks were higher after the close on Thursday, as gains in the , and sectors led shares higher.\n\nAt the close in Copenhagen, the gain...",
"url": "https://www.investing.com/news/stock-market-news/denmark-stocks-higher-at-close-of-trade-omx-copenhagen-20-up-001-3444480",
"image_url": "https://i-invdn-com.investing.com/news/LYNXMPEC0409P_L.jpg",
"language": "en",
"published_at": "2024-05-16T15:30:03.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "NVON.MX",
"name": "Novo Nordisk A/S",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 39.95773,
"sentiment_score": 0.7865,
"highlights": [
{
"highlight": "Genmab (CSE: ) declined 1.89% or 39.00 points to end at 2,026.00 and <em>Novo</em> <em>Nordisk</em> <em>A</em>/<em>S</em> Class B (CSE: ) was down 0.46% or 4.20 points to 912.90.\n\nRising stocks outnumbered declining ones on the Copenhagen Stock Exchange by 93 to 54 and 15 ended unchanged.\n\nShares in GN Store Nord (CSE: ) rose to 52-week highs; gaining 3.03% or 6.30 to 214.30.",
"sentiment": 0.7865,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "fed4429d-e359-4551-a1e7-131c0174599c",
"title": "Novo Nordisk : L'incendie Survenu Sur Le Site De Kalundborg N'a Pas...",
"description": "NOVO NORDISK : L'INCENDIE SURVENU SUR LE SITE DE KALUNDBORG N'A PAS D'INCIDENCE SUR LA PRODUCTION EXISTANTE ...",
"keywords": "Bourse",
"snippet": "Novo Nordisk A/S est spécialisé dans la conception, la fabrication et la commercialisation de produits pharmaceutiques. Le CA par famille de produits se répa...",
"url": "https://www.zonebourse.com/cours/action/NOVO-NORDISK-A-S-1412980/actualite/NOVO-NORDISK-L-INCENDIE-SURVENU-SUR-LE-SITE-DE-KALUNDBORG-N-A-PAS--46748687/",
"image_url": "https://www.zonebourse.com/images/twitter_ZB_fdblanc.png",
"language": "fr",
"published_at": "2024-05-16T13:26:48.000000Z",
"source": "zonebourse.com",
"relevance_score": null,
"entities": [
{
"symbol": "NVON.MX",
"name": "Novo Nordisk A/S",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 49.61238,
"sentiment_score": null,
"highlights": [
{
"highlight": "<em>Novo</em> <em>Nordisk</em> <em>A</em>/<em>S</em> est spécialisé dans la conception, la fabrication et la commercialisation de produits pharmaceutiques.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "NVON.MX",
"total_documents": 3,
"sentiment_avg": 0.43184999004006386
}
]
}
Other details
Exchange
- Mexican Stock Exchange
- equity
- Healthcare
- mx